Clinical Trial

Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate the benefits of gonadotropin-releasing hormone agonist administration during chemotherapy on preserving ovarian function and Fertility in Premenopausal breast cancer patients, as assessed by anti-mullerian hormone levels, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and estradiol (E2) levels.
Trial Details
NCT Number NCT07127315
Lead Sponsor Helwan University
Conditions Gonadotropin Releasing Hormone Agonists, Ovarian Function, Premenopausal, Breast Cancer, Chemotherapy
Enrollment 100 participants
Start Date 2022-06-01
Primary Completion 2024-07-01 (estimated)
Study Completion 2024-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-11